ArticleJournal of clinical medicine2020

Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data.

Julita Anna Krahel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.